Cochlear Implantation in the Elderly
Launched by HOSPICES CIVILS DE LYON · Aug 11, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of cochlear implants in elderly individuals, specifically those who are 80 years old and older. A cochlear implant is a device that helps people with severe hearing loss by directly stimulating the auditory nerve, which can improve their ability to hear and communicate. The goal of the study is to show that this treatment is effective and a good long-term option for older adults who have not had a cochlear implant before.
To participate in this trial, individuals must be 80 years or older and have never had a cochlear implant before. Unfortunately, those under 80 years old or who have had previous cochlear surgeries are not eligible. Participants can expect to receive a cochlear implant and be monitored over time to assess its effectiveness and how it impacts their quality of life. This study is actively recruiting participants, and it could provide valuable information about the benefits of cochlear implants specifically for the elderly population.
Gender
ALL
Eligibility criteria
- * Inclusion Criteria :
- • 80 years or more
- • Primo-implantation
- * Exclusion Criteria :
- • Under 80 years
- • Bilateralisation
- • Explantation or re-implantation
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported